Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
18.45
-0.56 (-2.95%)
May 15, 2026, 10:47 AM EDT - Market open

Avalo Therapeutics Stock Forecast

Stock Price Forecast

The 10 analysts that cover Avalo Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $45.2, which forecasts a 144.99% increase in the stock price over the next year. The lowest target is $15 and the highest is $60.

Price Target: $45.2 (+144.99%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$15$45.2$50$60
Change-18.70%+144.99%+171.00%+225.20%

Analyst Ratings

The average analyst rating for Avalo Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingDec '25Jan '26Feb '26Mar '26Apr '26May '26
Strong Buy556644
Buy333247
Hold111000
Sell000000
Strong Sell000000
Total99108811

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Citizens
Citizens
Buy
Maintains
$62$55
BuyMaintains$62$55+198.10%May 14, 2026
Wedbush
Wedbush
Buy
Maintains
$40$34
BuyMaintains$40$34+84.28%May 14, 2026
Mizuho
Mizuho
Buy
Maintains
$39$45
BuyMaintains$39$45+143.90%May 14, 2026
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$40$35
Strong BuyMaintains$40$35+89.70%May 14, 2026
Piper Sandler
Piper Sandler
Buy
Maintains
$48$60
BuyMaintains$48$60+225.20%May 11, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 59.00K
Revenue Next Year
n/a
EPS This Year
-3.44
from -5.84
EPS Next Year
-3.75
from -3.44
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
5.40M18.05M1.92M441.00K59.00K--
Revenue Growth
-19.42%234.40%-89.34%-77.08%-86.62%--
EPS
-2,331.41-1,062.65-113.58-20.91-5.84-3.44-3.75
EPS Growth
-------
Forward PE
-------
No. Analysts
-----1411
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20262027202820292030203120322033
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth20262027202820292030203120322033
High--
Avg--
Low--

EPS Forecast

EPS20262027202820292030203120322033
High-1.94-1.40
Avg-3.44-3.75
Low-3.94-4.80

EPS Growth

EPS Growth20262027202820292030203120322033
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.